Frank M Davis1, Debra L Rateri, Alan Daugherty. 1. aSection of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan bSaha Cardiovascular Research Center cDepartment of Physiology, University of Kentucky, Lexington, Kentucky, USA.
Abstract
PURPOSE OF REVIEW: Abdominal aortic aneurysm (AAA) is a pathological condition of permanent dilation that portends the potentially fatal consequence of aortic rupture. This review emphasizes recent advances in mechanistic insight into aneurysm pathogenesis and potential pharmacologic therapies that are on the horizon for AAAs. RECENT FINDINGS: An increasing body of evidence demonstrates that genetic factors, including 3p12.3, DAB2IP, LDLr, LRP1, matrix metalloproteinase (MMP)-3, TGFBR2, and SORT1 loci, are associated with AAA development. Current human studies and animal models have shown that many leukocytes and inflammatory mediators, such as IL-1, IL-17, TGF-β, and angiotensin II, are involved in the pathogenesis of AAAs. Leukocytic infiltration into aortic media leads to smooth muscle cell depletion, generation of reactive oxygen species, and extracellular matrix fragmentation. Preclinical investigations into pharmacological therapies for AAAs have provided intriguing insight into the roles of microRNAs in regulating many pathological pathways in AAA development. Several large clinical trials are ongoing, seeking to translate preclinical findings into therapeutic options. SUMMARY: Recent studies have identified many potential mechanisms involved in AAA pathogenesis that provide insight into the development of a medical treatment for this disease.
PURPOSE OF REVIEW: Abdominal aortic aneurysm (AAA) is a pathological condition of permanent dilation that portends the potentially fatal consequence of aortic rupture. This review emphasizes recent advances in mechanistic insight into aneurysm pathogenesis and potential pharmacologic therapies that are on the horizon for AAAs. RECENT FINDINGS: An increasing body of evidence demonstrates that genetic factors, including 3p12.3, DAB2IP, LDLr, LRP1, matrix metalloproteinase (MMP)-3, TGFBR2, and SORT1 loci, are associated with AAA development. Current human studies and animal models have shown that many leukocytes and inflammatory mediators, such as IL-1, IL-17, TGF-β, and angiotensin II, are involved in the pathogenesis of AAAs. Leukocytic infiltration into aortic media leads to smooth muscle cell depletion, generation of reactive oxygen species, and extracellular matrix fragmentation. Preclinical investigations into pharmacological therapies for AAAs have provided intriguing insight into the roles of microRNAs in regulating many pathological pathways in AAA development. Several large clinical trials are ongoing, seeking to translate preclinical findings into therapeutic options. SUMMARY: Recent studies have identified many potential mechanisms involved in AAA pathogenesis that provide insight into the development of a medical treatment for this disease.
Authors: Lars Maegdefessel; Junya Azuma; Ryuji Toh; Denis R Merk; Alicia Deng; Jocelyn T Chin; Uwe Raaz; Anke M Schoelmerich; Azad Raiesdana; Nicholas J Leeper; Michael V McConnell; Ronald L Dalman; Joshua M Spin; Philip S Tsao Journal: J Clin Invest Date: 2012-01-24 Impact factor: 14.808
Authors: Neil Ahluwalia; Alexander Y Lin; Andrew M Tager; Ivy E Pruitt; Thomas J T Anderson; Fjoralba Kristo; Dongxiao Shen; Anna R Cruz; Masanori Aikawa; Andrew D Luster; Robert E Gerszten Journal: J Immunol Date: 2007-07-01 Impact factor: 5.422
Authors: Lei Zhao; Michael P W Moos; Rolf Gräbner; Frédérique Pédrono; Jinjin Fan; Brigitte Kaiser; Nicole John; Sandra Schmidt; Rainer Spanbroek; Katharina Lötzer; Li Huang; Jisong Cui; Daniel J Rader; Jilly F Evans; Andreas J R Habenicht; Colin D Funk Journal: Nat Med Date: 2004-08-22 Impact factor: 53.440
Authors: Richard Yang Cao; Michael A Adams; Andreas J Habenicht; Colin D Funk Journal: Prostaglandins Other Lipid Mediat Date: 2007-03-24 Impact factor: 3.072
Authors: Elena Kaschina; Felix Schrader; Manuela Sommerfeld; Ulrich Rudolf Kemnitz; Aleksandra Grzesiak; Maxim Krikov; Thomas Unger Journal: J Hypertens Date: 2008-12 Impact factor: 4.844
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312